Literature DB >> 19052856

Short term effects of doxycycline on matrix metalloproteinases 2 and 9.

Nicola Fiotti1, Nicola Altamura, Michèle Moretti, Stella Wassermann, Serena Zacchigna, Rossella Farra, Barbara Dapas, Lara Consoloni, Mauro Giacca, Gabriele Grassi, Carlo Giansante.   

Abstract

PURPOSE: To investigate the short term effects of Doxycycline on MMP-2 and MMP-9.
METHODS: Short term effects of Doxycycline (100 mg B.I.D.) on plasma levels of MMP-2 and MMP-9 were investigated in 20 healthy subjects; the effects of Doxy, Acetylsalicylic acid, Nitrates, and Enalapril on MMP-9 release from were assessed in isolated polymorphonuclear cells.
RESULTS: In plasma, MMP-9 activity was reduced (-22%, 95% CI -32/-11; P = 0.002) starting at 12 h after doxy; in vitro, MMP-9 released from stimulated neutrophils was reduced by Doxy (-28%, 95% CI -43/-14; P = 0.001), inhibiting degranulation, and by nitrates (-52%, 95% CI -76/-28 P = 0.005), increasing three times both pro- and active-MMP-9 bound to neutrophils (P = 0.007 and 0.040, respectively).
CONCLUSIONS: Doxy decreases MMP-9 plasma levels by around 20%, within the first 12 h. The mechanism leading to such reduction seems due to the inhibition of PMN degranulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052856     DOI: 10.1007/s10557-008-6150-7

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  9 in total

1.  Targeted drug delivery to emphysematous lungs: Inhibition of MMPs by doxycycline loaded nanoparticles.

Authors:  Vaideesh Parasaram; Nasim Nosoudi; Renee J LeClair; Andrew Binks; Naren Vyavahare
Journal:  Pulm Pharmacol Ther       Date:  2016-06-25       Impact factor: 3.410

2.  Roles of matrix metalloproteinases in the etiology of inguinal hernia.

Authors:  A Aren; A H Gökçe; F S Gökçe; N Dursun
Journal:  Hernia       Date:  2011-07-08       Impact factor: 4.739

Review 3.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in chronic kidney disease and acute kidney injury: a systematic review of the literature.

Authors:  C L Sampieri; R A Orozco-Ortega
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

4.  Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus.

Authors:  Kathryn M Thrailkill; Cynthia S Moreau; Gael E Cockrell; Chan-Hee Jo; Robert C Bunn; Alba E Morales-Pozzo; Charles K Lumpkin; John L Fowlkes
Journal:  Endocrine       Date:  2010-01-12       Impact factor: 3.633

5.  Metalloproteinases and Their Inhibitors in Patients with Inguinal Hernia.

Authors:  Arda Isik; Cebrail Gursul; Kemal Peker; Merve Aydın; Deniz Fırat; İsmayil Yılmaz
Journal:  World J Surg       Date:  2017-05       Impact factor: 3.352

6.  Effect of doxycycline in patients of moderate to severe chronic obstructive pulmonary disease with stable symptoms.

Authors:  Prashant S Dalvi; Anil Singh; Hiren R Trivedi; Feroz D Ghanchi; Dinesh M Parmar; Suresh D Mistry
Journal:  Ann Thorac Med       Date:  2011-10       Impact factor: 2.219

Review 7.  Beneficial and Harmful Interactions of Antibiotics with Microbial Pathogens and the Host Innate Immune System.

Authors:  Ronald Anderson; Gregory Tintinger; Riana Cockeran; Moliehi Potjo; Charles Feldman
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-25

Review 8.  Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management.

Authors:  Philippe Eloy; Anne Lise Poirrier; Clotilde De Dorlodot; Thibaut Van Zele; Jean Baptiste Watelet; Bernard Bertrand
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

9.  Genetic Variants of Matrix Metalloproteinase and Sepsis: The Need Speed Study.

Authors:  Nicola Fiotti; Filippo Mearelli; Filippo Giorgio Di Girolamo; Luigi Mario Castello; Alessio Nunnari; Salvatore Di Somma; Enrico Lupia; Efrem Colonetti; Maria Lorenza Muiesan; Giuseppe Montrucchio; Carlo Giansante; Gian Carlo Avanzi; Gianni Biolo
Journal:  Biomolecules       Date:  2022-02-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.